๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD ยท Real-Time Price ยท USD
0.9226
-0.0774 (-7.74%)
At close: Nov 20, 2026, 4:00 PM EST
0.9300
+0.0074 (0.80%)
After-hours: Nov 20, 2026, 7:45 PM EST

Aardvark Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Income
-75.97-62.73-22.79-7.42-10.36
Net Income
-72.76-57.59-20.59-7.21-13.56
Earnings Per Share
-3.33-2.93-5.15-1.82-3.49
EPS Growth
-----

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
60.35110.0373.669.9916.11
Total Debt
0.570.440.780.160.26
Net Cash (Debt)
59.78109.5972.889.8315.84
Net Cash Growth
-52.49%50.36%641.67%-37.97%-
Net Cash Per Share
2.745.5818.242.484.07

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-66.81-54.17-18.09-5.82-10.54
Capital Expenditures
--0.1-0.11--
Free Cash Flow
-66.81-54.27-18.2-5.82-10.54
Free Cash Flow Growth
-----

Valuation

Selected indicators aren't available for this stock.